Glaxosmithkline Share Price (GSK)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 1,637.60on 05-06-2020 at 16:30:00
Change -13.60 -0.82%
Buy 1,634.00
Sell 1,633.60
Buy / Sell GSK Shares
Sponsored Financial Content
Last Trade: Buy 708 at 1,636.33p
Day's Volume: 7,865,371
Last Close: 1,651.20p
Open: 1,642.20p
ISIN: GB0009252882
Day's Range 1,628.00p - 1,651.00p
52wk Range: 1,328.60p - 1,857.00p
Market Capitalisation: £82,161m
VWAP: 0.00p
Shares in Issue: 5,017m

Recent Trades History Glaxosmithkline (GSK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy*7081,636.33Ordinary
Delayed publication
17:26:58 - 05-Jun-20
Buy*51,9821,637.60Ordinary
Delayed publication
17:10:37 - 05-Jun-20
Buy*41,3821,648.993Ordinary
Delayed publication
17:51:14 - 05-Jun-20
Buy*17,7891,636.859Ordinary
17:52:18 - 05-Jun-20
Buy*1,3071,635.834Ordinary
17:51:24 - 05-Jun-20
Buy*3,1001,637.60Ordinary
17:37:59 - 05-Jun-20
Sell*5391,631.105Ordinary
17:35:15 - 05-Jun-20
Buy*4,4831,634.517Ordinary
17:28:18 - 05-Jun-20
Buy*19,7501,636.167Ordinary
17:28:32 - 05-Jun-20
Buy*2,6001,634.604Ordinary
17:28:23 - 05-Jun-20

Share Price History for Glaxosmithkline

Time period:
to
Date Open High Low Close
3rd Jun 2020 (Wed)1,659.001,668.801,648.001,664.60
2nd Jun 2020 (Tue)1,650.801,662.201,640.601,649.00
1st Jun 2020 (Mon)1,691.601,691.601,654.401,657.70
29th May 2020 (Fri)1,679.601,691.001,653.601,689.20
28th May 2020 (Thu)1,641.001,693.201,641.001,689.20
27th May 2020 (Wed)1,646.601,666.001,624.001,646.10
26th May 2020 (Tue)1,688.401,689.201,630.801,646.10
25th May 2020 (Mon)00.000.001,667.70
22nd May 2020 (Fri)1,649.201,664.801,640.201,660.60
21st May 2020 (Thu)1,675.601,679.001,657.401,660.60
20th May 2020 (Wed)1,661.601,695.601,659.801,686.70
19th May 2020 (Tue)1,693.001,696.401,660.601,664.50
18th May 2020 (Mon)1,680.001,690.401,661.201,689.00
15th May 2020 (Fri)1,649.201,665.001,641.401,646.80
14th May 2020 (Thu)1,709.001,714.801,639.601,644.90
13th May 2020 (Wed)1,696.801,742.401,691.001,729.80
12th May 2020 (Tue)1,674.401,708.401,670.601,704.60
11th May 2020 (Mon)1,668.001,677.801,654.801,673.70
8th May 2020 (Fri)00.000.001,670.70
7th May 2020 (Thu)1,704.801,716.801,657.801,670.70
6th May 2020 (Wed)1,676.001,699.401,670.801,698.50

GSK - Glaxosmithkline Investor Summary

GlaxoSmithKline, or 'GSK', is one of the world's leading pharmaceutical companies researching medicines and vacines alike for the World Health Organization's three priority diseases: HIV/AIDS, Malaria and Tuberculosis. With an estimated 7% of the world's pharmaceutical market under its wing, GSK remains one of the industry leaders globally but remains committed to the research and application of life changing and marketable drugs.

If investing in science seems a little confusing and unpredictable then perhaps some of GSK's over-the-counter and more recognisable products will help to convince; these include Gaviscon and Panadol, smoking control products such as Nicorette/Niquitin and nutritional healthcare drinks such as Lucozade, Ribena and Horlicks.

On 23rd January 2009, GSK announced that it had signed an agreement with UCB S.A to acquire its marketed product portfolio in certain parts of the Middle East, Africa, Latin America and Asia Pacific, for a cash consideration of some £484 million. President of Emerging Markets at GSK, Abbas Hussain, said that "This acquisition will strengthen and expand GSK's product portfolio in these countries, helping us to meet the needs of patients, particularly in the areas of epilepsy and respiratory." Under the agreement, GSK acquires several leading pharmaceutical brands and investors will be interested to know that the commercial operations and product distribution rights included represent approximately 3-4% of UCB's 2008 expected revenue of at least £3.09 billion. At the time of Mr Hussain speaking, share prices for GSK were steady at 1,226.00p with a "strong buy" recommendation from brokers.

News about Glaxosmithkline (GSK)

FTSE soars on positive coronavirus vaccine trial results

News - Monday, May 18, 2020

The FTSE 100 passed an important psychological hurdle on Monday as it jumped ove......

FTSE jumps as countries open up from lockdown

News - Monday, May 18, 2020

UK stocks made strong gains on Monday as more countries continued to take tentat......

FTSE 100 Latest
Value6,484.30
Change142.86


Login to your account

Forgot Password?

Not Registered